Complement C5a inhibition: a new form of COVID-19 treatment for mechanically ventilated patients?

Andre C. Kalil; Michael Proschan

doi:10.1016/S2213-2600(22)00365-4

Complement C5a inhibition: a new form of COVID-19 treatment for mechanically ventilated patients?

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	1103-1104
Number of pages	2
Journal	The Lancet Respiratory Medicine
Volume	10
Issue number	12
DOIs	https://doi.org/10.1016/S2213-2600(22)00365-4
State	Published - Dec 2022

ASJC Scopus subject areas

Pulmonary and Respiratory Medicine

Access to Document

10.1016/S2213-2600(22)00365-4

Cite this

@article{c0fc0b2ef09c4ede8d12baff363983da,

title = "Complement C5a inhibition: a new form of COVID-19 treatment for mechanically ventilated patients?",

author = "Kalil, {Andre C.} and Michael Proschan",

year = "2022",

month = dec,

doi = "10.1016/S2213-2600(22)00365-4",

language = "English (US)",

volume = "10",

pages = "1103--1104",

journal = "The Lancet Respiratory Medicine",

issn = "2213-2600",

publisher = "Elsevier Ltd",

number = "12",

}

TY - JOUR

T1 - Complement C5a inhibition

T2 - a new form of COVID-19 treatment for mechanically ventilated patients?

AU - Kalil, Andre C.

AU - Proschan, Michael

PY - 2022/12

Y1 - 2022/12

UR - http://www.scopus.com/inward/record.url?scp=85142139947&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85142139947&partnerID=8YFLogxK

U2 - 10.1016/S2213-2600(22)00365-4

DO - 10.1016/S2213-2600(22)00365-4

M3 - Comment/debate

C2 - 36108660

AN - SCOPUS:85142139947

SN - 2213-2600

VL - 10

SP - 1103

EP - 1104

JO - The Lancet Respiratory Medicine

JF - The Lancet Respiratory Medicine

IS - 12

ER -

Complement C5a inhibition: a new form of COVID-19 treatment for mechanically ventilated patients?

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this